Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 12,418 | 11,129 | 12,643 | 16,824 | 13,267 |
| Cost of Goods | 4,643 | 5,420 | 3,506 | 4,787 | 5,592 |
| Gross Profit | 7,775 | 5,709 | 9,137 | 12,037 | 7,675 |
| Operating Expenses | 19,420 | 24,817 | 22,717 | 25,156 | 17,472 |
| Operating Income | -11,002 | -18,688 | -13,074 | -12,327 | -9,205 |
| Interest Expense | 2,652 | 1,937 | 1,926 | 1,924 | 1,933 |
| Other Income | -4,758 | 153 | 274 | 307 | -3,900 |
| Pre-tax Income | -18,412 | -20,472 | -14,726 | -13,944 | -15,038 |
| Net Income Continuous | -18,412 | -20,472 | -14,726 | -13,944 | -15,038 |
| Net Income | $-18,412 | $-20,472 | $-14,726 | $-13,944 | $-15,038 |
| EPS Basic Total Ops | -0.74 | -0.82 | -0.59 | -0.69 | -0.64 |
| EPS Basic Continuous Ops | -0.74 | -0.82 | -0.59 | -0.70 | -0.64 |
| EPS Diluted Total Ops | -0.74 | -0.82 | -0.59 | -0.69 | -0.64 |
| EPS Diluted Continuous Ops | -0.74 | -0.82 | -0.59 | -0.70 | -0.64 |
| EBITDA(a) | $-9,700 | $-17,536 | $-11,902 | $-11,173 | $-8,085 |